{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:40:20Z","timestamp":1760812820050,"version":"build-2065373602"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.trim.2019.101229","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T19:46:21Z","timestamp":1565120781000},"page":"101229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Immunoglobulin abnormalities in 1677 solid organ transplant recipients. Implications for posttransplantation follow-up."],"prefix":"10.1016","volume":"57","author":[{"suffix":"Jr","given":"Peter","family":"Se\u010dn\u00edk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton\u00edn","family":"Jabor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Lavr\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juraj","family":"Se\u010dn\u00edk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavl\u00edna","family":"Mal\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Pokorn\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janka","family":"Franekov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2019.101229_bb0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40164-017-0087-0","article-title":"Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients","volume":"6","author":"Bishnoi","year":"2017","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.trim.2019.101229_bb0010","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2141.2010.08161.x","article-title":"Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients \u2013 BCSH and BTS guidelines","volume":"5","author":"Parker","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.trim.2019.101229_bb0015","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1399-0012.2005.00388.x","article-title":"Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder","volume":"5","author":"Tsai","year":"2005","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2019.101229_bb0020","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/cncr.31339","article-title":"Impact of the posttransplant lymphoproliferative disorder subtype on survival","volume":"124","author":"Koff","year":"2018","journal-title":"Cancer."},{"key":"10.1016\/j.trim.2019.101229_bb0025","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1182\/blood.V98.5.1332","article-title":"Detection of gammopathy by serum protein electrophoresis for predicting and managing therapy of lymphoproliferative disorder in 911 recipients of liver transplants","volume":"5","author":"Lemoine","year":"2001","journal-title":"Blood."},{"key":"10.1016\/j.trim.2019.101229_bb0030","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/lt.500020508","article-title":"Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder","volume":"5","author":"Badley","year":"1996","journal-title":"Liver Transpl. Surg."},{"key":"10.1016\/j.trim.2019.101229_bb0035","doi-asserted-by":"crossref","first-page":"430209","DOI":"10.1155\/2013\/430209","article-title":"Posttransplant lymphoproliferative disease after lung transplantation","volume":"2013","author":"Neuringer","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.trim.2019.101229_bb0040","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/TP.0b013e3181e46a22","article-title":"Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report","volume":"3","author":"Opelz","year":"2010","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2019.101229_bb0045","doi-asserted-by":"crossref","first-page":"505","DOI":"10.5500\/wjt.v6.i3.505","article-title":"Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders","volume":"3","author":"Morscio","year":"2016","journal-title":"World J. Transplant."},{"key":"10.1016\/j.trim.2019.101229_bb0050","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/ajt.12640","article-title":"Adapted treatment of Epstein-Barr virus infection to prevent posttransplant lymphoproliferative disorder after he art transplantation","volume":"4","author":"Choquet","year":"2014","journal-title":"Am. J. Transplant."},{"issue":"9 Suppl 4","key":"10.1016\/j.trim.2019.101229_bb0055","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1111\/j.1600-6143.2009.02898.x","article-title":"AST Infectious Diseases Community of Practice. Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplant recipients","author":"Allen","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2019.101229_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13235","article-title":"Systematic review and meta-analysis of post-transplant lymphoproliferative disorder in lung transplant recipients","volume":"32","author":"Cheng","year":"2018","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2019.101229_bb0065","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.mcna.2016.01.006","article-title":"De novo malignancies after transplantation. Risk and surveillance strategies","volume":"100","author":"Doycheva","year":"2016","journal-title":"Med. Clin. N. Am."},{"key":"10.1016\/j.trim.2019.101229_bb0070","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ajh.21911","article-title":"Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States","volume":"86","author":"Quinlan","year":"2011","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.trim.2019.101229_bb0075","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1097\/TP.0000000000001884","article-title":"Monoclonal gammopathy of undetermined significance after kidney transplantation: single-center experience","volume":"11","author":"Alfano","year":"2017","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2019.101229_bb0080","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1093\/oxfordjournals.ndt.a027215","article-title":"Monoclonal gammopathy after intense induction immunosuppression in renal transplant patients","volume":"12","author":"Passweg","year":"1996","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.trim.2019.101229_bb0085","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/clinchem\/37.8.1334","article-title":"Monoclonal and oligoclonal gammopathies in heart-transplant recipients","volume":"8","author":"Myara","year":"1991","journal-title":"Clin. Chem."},{"key":"10.1016\/j.trim.2019.101229_bb0090","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000337482","article-title":"Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation","volume":"4","author":"Naina","year":"2012","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.trim.2019.101229_bb0095","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/TP.0b013e318274ab63","article-title":"Plasma markers of B-cell activation and clonality in pediatric liver and hematopoietic stem cell transplant recipients","volume":"3","author":"Engels","year":"2013","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2019.101229_bb0100","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1016\/j.transproceed.2004.09.046","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) is associated with an increased frequency of Epstein-Barr Virus (EBV) latently infected B lymphocytes in long-term renal transplant patients","volume":"9","author":"Babel","year":"2004","journal-title":"Transplant. Proc."},{"issue":"1\u20132","key":"10.1016\/j.trim.2019.101229_bb0105","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0041-1345(00)02602-6","article-title":"Monoclonal gammopathy in heart transplantation: risk factor analysis and relevance of immunosuppressive load","author":"Caforio","year":"2001","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2019.101229_bb0110","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/modpathol.3800080","article-title":"Post-transplant plasma cell myeloma and polymorphic lymphoproliferative disorder with monoclonal serum protein occurring in solid organ transplant recipients","volume":"4","author":"Sun","year":"2004","journal-title":"Mod. Pathol."},{"issue":"Suppl. 1","key":"10.1016\/j.trim.2019.101229_bb0115","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1111\/tri.1992.5.s1.23","article-title":"Monoclonal immunoglobulins in patients with renal transplants: characterization, evolution and risk factors","volume":"5","author":"Chakalarovski","year":"1992","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2019.101229_bb0120","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/TP.0b013e318225db2c","article-title":"Monoclonal gammopathy of undetermined significance does not affect outcomes in patients undergoing solid organ transplants","volume":"5","author":"Jimenez-Zepeda","year":"2011","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2019.101229_bb0125","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.transproceed.2015.08.023","article-title":"Outcomes of monoclonal gammopathy of undetermined significance in patients who underwent kidney transplantation","volume":"8","author":"Bancu","year":"2015","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2019.101229_bb0130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.transproceed.2014.11.021","article-title":"Follow-up monoclonal gammopathy of undetermined significance in kidney transplant","volume":"1","author":"Cu\u00e9llar-Garc\u00eda","year":"2015","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2019.101229_bb0135","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00007890-198809000-00011","article-title":"High incidence of monoclonal immunoglobulins in patients after liver or heart transplantation","volume":"3","author":"Peest","year":"1988","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2019.101229_bb0140","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/ndt\/12.6.1199","article-title":"High prevalence and usual persistence of serum monoclonal immunoglobulins evidenced by sensitive methods in renal transplant recipients","volume":"6","author":"Touchard","year":"1997","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.trim.2019.101229_bb0145","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1097\/TP.0b013e31823bb62b","article-title":"Progression of monoclonal gammopathy of undetermined significance to multiple myeloma in a solid organ transplant","volume":"12","author":"Redfield","year":"2011","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2019.101229_bb0150","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1399-0012.2011.01539.x","article-title":"Initial survival data of kidney transplant patients with pre-transplant monoclonal gammopathy","volume":"2","author":"Soltero","year":"2012","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2019.101229_bb0155","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1399-0012.2005.00388.x","article-title":"Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder","volume":"5","author":"Tsai","year":"2005","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2019.101229_bb0160","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/ctr.12482","article-title":"Multiple myeloma after kidney transplantation","volume":"1","author":"Safadi","year":"2015","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2019.101229_bb0165","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1182\/blood.V124.21.5883.5883","article-title":"Comparison of free light chain assay with protein electrophoresis for screening and monitoring PTLD","volume":"124","author":"Kuhn","year":"2014","journal-title":"Blood."},{"key":"10.1016\/j.trim.2019.101229_bb0170","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00007890-199802150-00018","article-title":"Prevalence of monoclonal immunoglobulins after liver transplantation: relationship with posttransplant lymphoproliferative disorders","volume":"3","author":"Pageaux","year":"1998","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2019.101229_bb0175","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/ctr.12595","article-title":"Neoplastic and non-neoplastic complications of solid organ transplantation in patients with preexisting monoclonal gammopathy of undetermined significance","volume":"9","author":"Goebel","year":"2015","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2019.101229_bb0180","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1258\/acb.2011.011158","article-title":"Recommendations for standardized reporting of protein electrophoresis in Australia and New Zealand","volume":"3","author":"Tate","year":"2012","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.trim.2019.101229_bb0185","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"20","author":"Swerdlow","year":"2016","journal-title":"Blood."},{"key":"10.1016\/j.trim.2019.101229_bb0190","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"446","author":"Fine","year":"1999","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.trim.2019.101229_bb0195","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"13","author":"Kyle","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2019.101229_bb0200","article-title":"Immunophenotypic profile and clinical outcome of monoclonal B-cell lymphocytosis in kidney transplantation","volume":"8","author":"Alfano","year":"2018","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2019.101229_bb0205","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1600-6143.2011.03954.x","article-title":"Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder","volume":"5","author":"Engels","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2019.101229_bb0210","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"6","author":"Kyle","year":"2010","journal-title":"Leukemia."},{"key":"10.1016\/j.trim.2019.101229_bb0215","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"12","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.trim.2019.101229_bb0220","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1432-2277.2011.01362.x","article-title":"Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies","volume":"1","author":"Galioto","year":"2012","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2019.101229_bb0225","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","article-title":"Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant","volume":"22","author":"Leung","year":"2012","journal-title":"Blood."},{"key":"10.1016\/j.trim.2019.101229_bb0230","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders","volume":"2","author":"Dispenzieri","year":"2009","journal-title":"Leukemia."},{"key":"10.1016\/j.trim.2019.101229_bb0235","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1373\/clinchem.2009.126664","article-title":"Screening panels for detection of monoclonal gammopathies","volume":"8","author":"Katzmann","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.trim.2019.101229_bb0240","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"3","author":"Rajkumar","year":"2005","journal-title":"Blood."},{"key":"10.1016\/j.trim.2019.101229_bb0245","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.trim.2017.01.003","article-title":"Free light chain and intact immunoglobulin abnormalities in heart transplant recipients: two year follow-up timelines and clinical correlations","volume":"41","author":"Se\u010dn\u00edk","year":"2017","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.trim.2019.101229_bb0250","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3324\/haematol.2010.039214","article-title":"Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases","volume":"7","author":"Trappe","year":"2011","journal-title":"Haematologica."},{"key":"10.1016\/j.trim.2019.101229_bb0255","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1182\/blood-2013-01-475947","article-title":"Plasma cell tumors in transplant patients","volume":"8","author":"Nalesnik","year":"2013","journal-title":"Blood."},{"key":"10.1016\/j.trim.2019.101229_bb0260","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/tri.12091","article-title":"Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patients","volume":"6","author":"Karuturi","year":"2013","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2019.101229_bb0265","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1309\/AJCP4INKZ6LYAQXW","article-title":"Extended use of serum free light chain as a biomarker in lymphoproliferative disorders: a comprehensive review","volume":"6","author":"Charafeddine","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.trim.2019.101229_bb0270","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1373\/clinchem.2008.117143","article-title":"Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine","volume":"3","author":"Palladini","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.trim.2019.101229_bb0275","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.trsl.2006.11.001","article-title":"Serum-free light chain-a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia","volume":"4","author":"Martin","year":"2007","journal-title":"Transl. Res."},{"key":"10.1016\/j.trim.2019.101229_bb0280","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1200\/JCO.2010.29.4413","article-title":"Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma","volume":"12","author":"Maurer","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trim.2019.101229_bb0315","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.3109\/10428194.2013.764423","article-title":"Serum free light chains and post-transplant lymphoproliferative disorder in patients with renal transplant","volume":"10","author":"Fernando","year":"2013","journal-title":"Leuk. Lymphoma"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632741930053X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632741930053X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:59:28Z","timestamp":1760810368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096632741930053X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":57,"alternative-id":["S096632741930053X"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2019.101229","relation":{},"ISSN":["0966-3274"],"issn-type":[{"type":"print","value":"0966-3274"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoglobulin abnormalities in 1677 solid organ transplant recipients. Implications for posttransplantation follow-up.","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2019.101229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101229"}}